Found: 11
Select item for more details and to access through your institution.
Monoclonal Antibody-Based Therapies for Myasthenia Gravis.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 557, doi. 10.1007/s40259-020-00443-w
- By:
- Publication type:
- Article
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 681, doi. 10.1007/s40259-020-00438-7
- By:
- Publication type:
- Article
PF-06410293: An Adalimumab Biosimilar.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 695, doi. 10.1007/s40259-020-00445-8
- By:
- Publication type:
- Article
Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 669, doi. 10.1007/s40259-020-00442-x
- By:
- Publication type:
- Article
Correction to: Assessment of Structural and Functional Comparability of Biosimilar Products: Trastuzumab as a Case Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Innovative Therapies for Hemoglobin Disorders.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 625, doi. 10.1007/s40259-020-00439-6
- By:
- Publication type:
- Article
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 649, doi. 10.1007/s40259-020-00444-9
- By:
- Publication type:
- Article
Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 543, doi. 10.1007/s40259-020-00437-8
- By:
- Publication type:
- Article
Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 611, doi. 10.1007/s40259-020-00436-9
- By:
- Publication type:
- Article
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 587, doi. 10.1007/s40259-020-00435-w
- By:
- Publication type:
- Article
Designer Exosomes: A New Platform for Biotechnology Therapeutics.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 567, doi. 10.1007/s40259-020-00434-x
- By:
- Publication type:
- Article